ACE inhibitor slows onset of renal disease in diabetics by 50%
Lefton, C.K.
Nephrology News and Issues 7(12): 8; 11
1993
ISSN/ISBN: 0896-1263 PMID: 8264813 Document Number: 412388
Document emailed within 1 workday
Related Documents
Henry, M.L.; Ketel, B.L.; Elkhammas, E.A.; Tesi, R.J.; Ferguson, R.M. 1990: The role of transplantation in diabetics with end-stage renal disease Clinical Transplants 1990: 203-215Kobierska-Szczepańska, A.; Bober, E.; Mazur, H. 1979: Cacchi and Ricci disease with early onset of renal disease in a 17-year-old boy Wiadomosci Lekarskie 32(15): 1087-1090
Tapolyai, M.; Schede Don, K.; Gupta, B. 1999: Rhu-erythropoietin treatment of pre-ESRD patients slows the rate of progression of renal decline Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 91A
Lai, C.-H.; Hsu, Y.-W.; Lee, J.-T.; Hsu, Y.-D.; Cheng, C.-A.; Tsai, C.-K. 2017: Acute Onset of Parkinsonism an End-Stage Renal Disease Patient Acta Neurologica Taiwanica 26(2): 64-67
Andersch, H.; Arzberger, H.; Köhler, W. 1970: Ankylosing hyperostosis of the spine (Forestier's disease) in diabetics. Systematic x-ray examinations of 1,000 diabetics Das Deutsche Gesundheitswesen 25(42): 1991-1994
Spalter, H.F. 1972: Diabetic maculopathy in maturity onset diabetics Israel Journal of Medical Sciences 8(8): 1341-1343
Schlumpf, U. 1978: The effect of diclofenac sodium on the metabolism of diabetics in qualitative diet therapy with an without tolbuamide. a clinically oriented study in aged diabetics with rheumatic disease Schweizerische Medizinische Wochenschrift 108(1): 28-34
Bunnag, S.C.; Israsena, T.; Watananukul, P. 1972: Blood coagulation in maturity--onset diabetics before and after treatment with glibenclamide Journal of the Medical Association of Thailand 55(2): 80-86
Lenhard, M.J. 1995: Predicting renal disease in type i diabetics: smoke and fire or smoke and mirrors? Delaware Medical Journal 67(7): 378-387
Haider, Z.; Obaidullah, S.; Fayyaz-ud-Din 1976: Comparative study of glibenclamide and chlorpropamide in newly diagnosed maturity onset diabetics JPMA. Journal of the Pakistan Medical Association 26(2): 23-26
Badran, A.M.; Farid, F.F. 1977: Effect of weight reduction on the glucose tolerance in obese maturity onset diabetics Journal of the Egyptian Public Health Association 52(6): 425-431
Haider, Z.; Obaidullah, S.; Fayyaz-ud-Din 1976: Comparative study of glibenclamide & chlorpropamide in newly diagnosed maturity onset diabetics Jpma. Journal of the Pakistan Medical Association 26(2): 23-26
Slama, G. 2001: Is it necessary to systematically treat diabetics with polytherapy at onset? Is it necessary to aim toward a precocious systematic polychemotherapy in type 2 diabetes? Journees Annuelles de Diabetologie de l'Hotel-Dieu 2001: 221-228
Hwang, J.S.; Juang, J.H. 1998: Clinical courses and changes of pancreatic beta-cell function in young-onset diabetics: report of two cases Changgeng Yi Xue Za Zhi 21(3): 328-332
Rosolová, H.; Cech, F.; Sefrna, F. 2002: Treatment of hypertension in diabetics with trandolapril, an angiotensin converting enzyme inhibitor--a multicenter study Vnitrni Lekarstvi 48(8): 701-706
Hattori, M.; Iwano, M.; Sako, M.; Honda, M.; Okada, H.; Akioka, Y.; Ashida, A.; Kawasaki, Y.; Kiyomoto, H.; Terada, Y.; Hirano, D.; Fujieda, M.; Fujimoto, S.; Masaki, T.; Maruyama, S.; Mastuo, S. 2016: Transition of adolescent and young adult patients with childhood-onset chronic kidney disease from pediatric to adult renal services: a nationwide survey in Japan Clinical and Experimental Nephrology 20(6): 918-925
Caputo, R.P.; Giambartolomei, A.; Simons, A.; Reger, M.; Wagner, S.; Esente, P. 2001: Adjunctive therapies in the cath lab. use of combination glycoprotein IIb/IIIa inhibitor and direct thrombin inhibitor drugs to support percutaneous coronary stent placement in a patient with renal insufficiency and heparin-induced thrombocytopenia Journal of Invasive Cardiology 13(9): 657-660
Svarstad, E.; Hultstrøm, D.; Jensen, D.; Jenssen, G.; Gravendeel, J.; Iversen, B.M. 2001: Acute renal failure, renal artery stenosis and angiotensin-converting enzyme (ACE) inhibitor Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 121(15): 1784-1788
Aoi, W.; Akahoshi, M.; Takahara, A.; Doi, Y.; Seto, S.; Kusano, E.; Suzuki, S.; Hashida, K.; Takagi, H.; Yoshioka, M. 1985: Effects of angiotensin i converting enzyme inhibitor on renal function and serum potassium in renal and renovascular hypertension Nihon Jinzo Gakkai Shi 27(11): 1571-1583
Marín, R.; Coca, A.; Tranche, S.; Rodríguez Mañas, L.; Abellán, J.; Moyá, A. 2002: Prevalence of renal involvement in a population of type Ii diabetics followed up in primary care Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 22(2): 152-161